F Tona1, R Serra2, L Di Ascenzo1, E Osto1, A Scarda2, R Fabris2, R Montisci3, G Famoso1, S Tellatin1, M Foletto4, A Giovagnoni5, S Iliceto1, R Vettor6. 1. Department of Cardiologic, Thoracic and Vascular Sciences, University of Cagliari, Cagliari, Italy. 2. Internal Medicine 3, Center for the Study and Integrated Treatment of the Obesity, Bariatric Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy. 3. Department of Cardiological and Neurological Sciences, University of Cagliari, Cagliari, Italy. 4. Department of Surgical, Oncological and Gastroenterological Sciences, 1st Surgical Clinic, University of Padua, Padua, Italy. 5. Department of Radiology, Abano Terme Hospital, Padua, Italy. 6. Internal Medicine 3, Center for the Study and Integrated Treatment of the Obesity, Bariatric Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy. Electronic address: roberto.vettor@unipd.it.
Abstract
BACKGROUND AND AIMS: Obesity, systemic inflammation and changes in the heart functions are associated with increased cardiovascular risk. This study aimed to investigate coronary microvascular dysfunction as an early marker of atherosclerosis in obese patients without any evidence of cardiovascular disease. METHODS AND RESULTS: 86 obese subjects (aged 44 ± 12 years, body mass index (BMI) 41 ± 8 kg m(-2)), without evidence of heart disease, and 48 lean controls were studied using transthoracic Doppler echocardiography for detecting coronary flow reserve (CFR). A value of CFR ≤ 2.5 was considered abnormal. We measured interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and adiponectin in all patients. Patients with abnormal CFR underwent coronary multislice computed tomography (MSCT) in order to exclude an epicardial stenosis. CFR in obese subjects was lower than in lean subjects (3.2 ± 0.8 vs. 3.7 ± 0.7, p = 0.02) and was abnormal in 27 (31%) obese patients and in one (2%) control (p < 0.0001). All subjects with abnormal CFR showed no coronary stenosis at MSCT. At multivariable analysis, IL-6 and TNF-α were the only determinants of CFR (p < 0.02 and p < 0.02, respectively). At multivariable logistic regression analysis, IL-6 and TNF-α were the only determinants of CFR ≤ 2.5 (p < 0.03 and p < 0.03, respectively). CONCLUSIONS: CFR is often reduced in obese subjects without clinical evidence of heart disease, suggesting a coronary microvascular impairment. This microvascular dysfunction seems to be related to a chronic inflammation mediated by adipocytokines. Our findings may explain the increased cardiovascular risk in obesity, independently of BMI.
BACKGROUND AND AIMS: Obesity, systemic inflammation and changes in the heart functions are associated with increased cardiovascular risk. This study aimed to investigate coronary microvascular dysfunction as an early marker of atherosclerosis in obesepatients without any evidence of cardiovascular disease. METHODS AND RESULTS: 86 obese subjects (aged 44 ± 12 years, body mass index (BMI) 41 ± 8 kg m(-2)), without evidence of heart disease, and 48 lean controls were studied using transthoracic Doppler echocardiography for detecting coronary flow reserve (CFR). A value of CFR ≤ 2.5 was considered abnormal. We measured interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and adiponectin in all patients. Patients with abnormal CFR underwent coronary multislice computed tomography (MSCT) in order to exclude an epicardial stenosis. CFR in obese subjects was lower than in lean subjects (3.2 ± 0.8 vs. 3.7 ± 0.7, p = 0.02) and was abnormal in 27 (31%) obesepatients and in one (2%) control (p < 0.0001). All subjects with abnormal CFR showed no coronary stenosis at MSCT. At multivariable analysis, IL-6 and TNF-α were the only determinants of CFR (p < 0.02 and p < 0.02, respectively). At multivariable logistic regression analysis, IL-6 and TNF-α were the only determinants of CFR ≤ 2.5 (p < 0.03 and p < 0.03, respectively). CONCLUSIONS: CFR is often reduced in obese subjects without clinical evidence of heart disease, suggesting a coronary microvascular impairment. This microvascular dysfunction seems to be related to a chronic inflammation mediated by adipocytokines. Our findings may explain the increased cardiovascular risk in obesity, independently of BMI.
Authors: Navkaranbir S Bajaj; Michael T Osborne; Ankur Gupta; Ali Tavakkoli; Paco E Bravo; Tomas Vita; Courtney F Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Deepak L Bhatt; Marcelo F Di Carli; Viviany R Taqueti Journal: J Am Coll Cardiol Date: 2018-08-14 Impact factor: 24.094
Authors: Christina Byrne; Philip Hasbak; Andreas Kjaer; Jens Jakob Thune; Lars Køber Journal: Int J Cardiovasc Imaging Date: 2017-12-28 Impact factor: 2.357
Authors: Borek Foldyna; Roman Zeleznik; Parastou Eslami; Thomas Mayrhofer; Jan-Erik Scholtz; Maros Ferencik; Daniel O Bittner; Nandini M Meyersohn; Stefan B Puchner; Hamed Emami; Patricia A Pellikka; Hugo J W L Aerts; Pamela S Douglas; Michael T Lu; Udo Hoffmann Journal: Eur Radiol Date: 2021-01-26 Impact factor: 7.034
Authors: Rajesh Mohandas; Mark S Segal; Tianyao Huo; Eileen M Handberg; John W Petersen; B Delia Johnson; George Sopko; C Noel Bairey Merz; Carl J Pepine Journal: PLoS One Date: 2015-05-07 Impact factor: 3.240
Authors: Kim A Dora; Lyudmyla Borysova; Xi Ye; Chloe Powell; Timea Z Beleznai; Christopher P Stanley; Vito D Bruno; Tobias Starborg; Errin Johnson; Anna Pielach; Michael Taggart; Nicola Smart; Raimondo Ascione Journal: Cardiovasc Res Date: 2022-06-29 Impact factor: 13.081